Response and outcome in the 19 evaluable patients
| UPN . | Response after 3 mo* . | Daily imatinib dosage, mg . | Response after 6 mo . | Daily imatinib dosage, mg . | Status . | Continues imatinib . | Duration of imatinib treatment, mo . | Concomitant steroid therapy . |
|---|---|---|---|---|---|---|---|---|
| 1 | NR | 100 | PR | 100 | Dead | No | 8 | Yes |
| 1064 | MxR | 100 | PR | 100 | Dead | No | 6 | Stop |
| 99991 | PR | 100 | CR | 100 | Alive | Yes | 16 | Yes |
| 99992 | NR | 100 | CR | 50 | Dead | No | 6 | Yes |
| 1467 | PR | 100 | CR | 100 | Alive | Yes | 10 | Stop |
| 1602 | PR | 100 | PR | 100 | Alive | No | 6 | Yes |
| 434 | PR | 100 | PR | 100 | Alive | Yes | 11 | Yes |
| 1346 | NR | 100 | NR | 100 | Alive | No | 6 | Yes |
| 122 | PR | 100 | PR | 200 | Alive | Yes | 15 | Decrease 50% |
| 143 | PR | 100 | PR | 100 | Alive | Yes | 9 | Decrease 70% |
| 1027 | PR | 100 | PR | 100 | Alive | Yes | 7 | Stop |
| 310AR | PR | 100 | CR | 100 | Alive | Yes | 11 | Stop |
| 1992MP | CR | 100 | CR | 100 | Alive | Yes | 12 | Yes |
| 401PP | MR | 100 | MR | 100 | Alive | No | 8 | Stop |
| 8881047 | PR | 100 | CR | 100 | Alive | Yes | 13 | Stop |
| 1023015 | PR | 100 | CR | 100 | Alive | Yes | 13 | Stop |
| 1025779 | NR | 100 | NR | 100 | Alive | No | 6 | Increase 50% |
| 1024411 | NR | 100 | NR | 100 | Alive | No | 6 | Increase 50% |
| 9999450 | PR | 100 | PR | 200 | Alive | Yes | 9 | Decrease 80% |
| Total 19 pt | CR + Pr 12 | CR + Pr 15 | 16/19 | 11/8 | 6-16(9) | 7 stop, 3 decrease, 2 increase |
| UPN . | Response after 3 mo* . | Daily imatinib dosage, mg . | Response after 6 mo . | Daily imatinib dosage, mg . | Status . | Continues imatinib . | Duration of imatinib treatment, mo . | Concomitant steroid therapy . |
|---|---|---|---|---|---|---|---|---|
| 1 | NR | 100 | PR | 100 | Dead | No | 8 | Yes |
| 1064 | MxR | 100 | PR | 100 | Dead | No | 6 | Stop |
| 99991 | PR | 100 | CR | 100 | Alive | Yes | 16 | Yes |
| 99992 | NR | 100 | CR | 50 | Dead | No | 6 | Yes |
| 1467 | PR | 100 | CR | 100 | Alive | Yes | 10 | Stop |
| 1602 | PR | 100 | PR | 100 | Alive | No | 6 | Yes |
| 434 | PR | 100 | PR | 100 | Alive | Yes | 11 | Yes |
| 1346 | NR | 100 | NR | 100 | Alive | No | 6 | Yes |
| 122 | PR | 100 | PR | 200 | Alive | Yes | 15 | Decrease 50% |
| 143 | PR | 100 | PR | 100 | Alive | Yes | 9 | Decrease 70% |
| 1027 | PR | 100 | PR | 100 | Alive | Yes | 7 | Stop |
| 310AR | PR | 100 | CR | 100 | Alive | Yes | 11 | Stop |
| 1992MP | CR | 100 | CR | 100 | Alive | Yes | 12 | Yes |
| 401PP | MR | 100 | MR | 100 | Alive | No | 8 | Stop |
| 8881047 | PR | 100 | CR | 100 | Alive | Yes | 13 | Stop |
| 1023015 | PR | 100 | CR | 100 | Alive | Yes | 13 | Stop |
| 1025779 | NR | 100 | NR | 100 | Alive | No | 6 | Increase 50% |
| 1024411 | NR | 100 | NR | 100 | Alive | No | 6 | Increase 50% |
| 9999450 | PR | 100 | PR | 200 | Alive | Yes | 9 | Decrease 80% |
| Total 19 pt | CR + Pr 12 | CR + Pr 15 | 16/19 | 11/8 | 6-16(9) | 7 stop, 3 decrease, 2 increase |
NR indicates no response; PR, partial remission; MxR, mixed response; CR, complete remission; and MR, minor response.